tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Income Statement

Compare
610 Followers

MoonLake Immunotherapeutics Income Statement

Last quarter (Q3 2025), MoonLake Immunotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MoonLake Immunotherapeutics's net income was $-69.73M. See MoonLake Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -4.97K$ 0.00
Operating Expenses
$ 143.09M$ 54.12M$ 65.06M$ 53.57M$ 105.75K
Depreciation and Amortization
$ 1.38M$ 370.32K$ 164.78K$ 4.97K$ 0.00
EBITDA
$ -141.71M$ -53.75M$ -64.90M$ -53.63M$ -90.84K
Operating Income
$ -143.09M$ -54.12M$ -65.06M$ -53.58M$ -105.75K
Other Income/Expenses
$ 22.13M$ 10.14M$ 591.73K$ -61.85K$ 14.92K
Pretax Income
$ -120.96M$ -43.98M$ -64.47M$ -53.64M$ -90.84K
Net Income
$ -118.94M$ -36.01M$ -49.97M$ -53.64M$ -90.84K
Per Share Metrics
Basic EPS
$ -1.89$ -0.73$ -2.20$ -1.45$ -0.01
Diluted EPS
$ -1.89$ -0.73$ -2.20$ -1.45$ -0.01
Weighted Average Shares Outstanding
62.87M 49.12M 29.36M 36.93M 14.80M
Weighted Average Shares Outstanding (Diluted)
62.87M 49.12M 29.36M 36.93M 14.80M
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History